홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

1-Ethyl-3-(3'-dimethylaminopropyl)carbodiimide → 6-(2',6'-Diaminohexanoylamino)-3,4,5-Trihydroxytetra-Hydropyran-2-ylmethyl 10,12-Tricosadiynoate

HRID 1734975
인쇄

반응식

HRID 1734975 반응식
[NH2:1][C@@H:2]1[O:10][C@H:9]([CH2:11][OH:12])[C@H:7]([OH:8])[C@H:5]([OH:6])[C@H:3]1[OH:4].[NH:13](C(OCC1C2C(=CC=CC=2)C2C1=CC=CC=2)=O)[C@H:14]([C:27](OC1C(F)=C(F)C(F)=C(F)C=1F)=[O:28])[CH2:15][CH2:16][CH2:17][CH2:18][NH:19]C(OC(C)(C)C)=O.[C:58]([OH:82])(=O)[CH2:59][CH2:60][CH2:61][CH2:62][CH2:63][CH2:64][CH2:65][CH2:66][C:67]#[C:68][C:69]#[C:70][CH2:71][CH2:72][CH2:73][CH2:74][CH2:75][CH2:76][CH2:77][CH2:78][CH2:79][CH3:80].C(N=C=NCCCN(C)C)C>CN(C)C=O>[C:58]([O:12][CH2:11][CH:9]1[CH:7]([OH:8])[CH:5]([OH:6])[CH:3]([OH:4])[CH:2]([NH:1][C:27](=[O:28])[CH:14]([NH2:13])[CH2:15][CH2:16][CH2:17][CH2:18][NH2:19])[O:10]1)(=[O:82])[CH2:59][CH2:60][CH2:61][CH2:62][CH2:63][CH2:64][CH2:65][CH2:66][C:67]#[C:68][C:69]#[C:70][CH2:71][CH2:72][CH2:73][CH2:74][CH2:75][CH2:76][CH2:77][CH2:78][CH2:79][CH3:80]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

6

반응물 4

HCID 159081-Ethyl-3-(3'-dimethylaminopropyl)carbodiimideHCID 53845710,12-Tricosadiynoic AcidHCID 11095207(2R,3R,4S,5R,6R)-2-Amino-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triolHCID 11146634Fmoc-Lys(Boc)-OPfp

생성물 1

HCID 186889666-(2',6'-Diaminohexanoylamino)-3,4,5-Trihydroxytetra-Hydropyran-2-ylmethyl 10,12-Tricosadiynoate

시약·촉매·용매 1

HCID 6228Dimethylformamide용매2회

실험 절차

1-Amino-1-deoxy-β-D-galactose (180 mg, 1 mmol), and Fmoc-Lys(Boc)-OPfp (650 mg, 1 mmol) were dissolved in 4 ml dry dimethylformamide and stirred at room temperature overnight. The solvent was removed in vacuo, the residue was redissolved in acetonitrile/water (1:1), filtered and purified by reversed phase chromatography (Lobar RP8B, acetonitrile/water 50:50 and 65:35). The relevant fractions were collected, concentrated in vacuo, and the product was characterised by NMR. The purified product (1 g, 1 mmol), 10,12-tricosadiynoic acid (350 mg, 1 mmol) and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide are dissolved in 10 ml dry dimethylformamide and stirred at room temperature overnight. The solvent is removed in vacuo, the residue redissolved in chloroform/methanol (95:5), filtered and purified by straight phase chromatography on a CHROMATOTRON. The relevant fractions are collected, concentrated in vacuo, and the product is characterised by NMR. The protecting groups of the α-ε amino groups are removed by standard reactions. Boc is removed by treatment with trifluoroacetic acid/methylene chloride for 30 minutes. The solvent is removed in vacuo. Fmoc is removed by treating the residue with 20% piperidine in dimethylformamide for 30 minutes, and the solvent is removed in vacuo. The final product is purified by reversed phase chromatography (Lobar RP8B).

후처리

  1. customThe solvent was removed in vacuo
  2. dissolutionthe residue was redissolved in acetonitrile/water (1:1)
  3. filtrationfiltered
  4. custompurified by reversed phase chromatography (Lobar RP8B, acetonitrile/water 50:50 and 65:35)
  5. customThe relevant fractions were collected
  6. concentrationconcentrated in vacuo
  7. stirringstirred at room temperature overnight
  8. customThe solvent is removed in vacuo
  9. dissolutionthe residue redissolved in chloroform/methanol (95:5)
  10. filtrationfiltered
  11. custompurified by straight phase chromatography on a CHROMATOTRON
  12. customThe relevant fractions are collected
  13. concentrationconcentrated in vacuo
  14. customThe protecting groups of the α-ε amino groups are removed by standard reactions
  15. customBoc is removed by treatment with trifluoroacetic acid/methylene chloride for 30 minutes
  16. customThe solvent is removed in vacuo
  17. customFmoc is removed
  18. additionby treating the residue with 20% piperidine in dimethylformamide for 30 minutes
  19. customthe solvent is removed in vacuo
  20. customThe final product is purified by reversed phase chromatography (Lobar RP8B)

출처 및 근거

ORD 기록
ord-c4ad291310a940bbb8362edb620f875f
출처 데이터셋
uspto-grants-1996_07
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US05536490

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트